Assoc. Prof. Dr. Zubair Anwar | Pharmaceutical Chemistry | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Assoc. Prof. Dr. Zubair Anwar | Pharmaceutical Chemistry | Best Researcher Award

Assoc. Prof. Dr. Zubair Anwar | Pharmaceutical Chemistry | Best Researcher Award 

Assoc. Prof. Dr. Zubair Anwar , Baqai Medical University , Pakistan 

Dr. Zubair Anwar, a distinguished pharmaceutical chemist from Pakistan, is known for his expertise in photodegradation, photostabilization, and the pharmaceutical applications of riboflavin and other compounds. He completed his Ph.D. in Pharmaceutical Chemistry at Baqai Medical University, Karachi, and pursued postdoctoral research at Adam Mickiewicz University, Poland. Dr. Zubair Anwar has made significant contributions to pharmaceutical quality control and photophysical research, evidenced by numerous publications in reputed journals. Currently serving as Associate Professor and Deputy Director at Baqai Medical University, he is deeply involved in academia, research supervision, and innovative pharmaceutical projects. His work emphasizes the development of stable pharmaceutical formulations, highlighting his role as a pivotal figure in pharmaceutical chemistry in Pakistan.

Professional Profile:

Orcid  Profile

Scopus  Profile 

Summary of Suitability for Award:

Assoc. Prof. Dr. Zubair Anwar holds an advanced academic position, having earned his Ph.D. and currently serving as an Associate Professor. Assoc. Prof. Dr. Zubair Anwar has demonstrated a consistent record of impactful research, a robust publication history, and meaningful contributions to his field, he would be highly suitable for the “Best Researcher Awards.” His qualifications, research focus, mentorship role, and engagement in significant projects or collaborations are critical indicators of his eligibility. If the detailed data supports his achievements in these areas, he would be a strong contender for this prestigious award.

🎓Education:

Assoc. Prof. Dr. Zubair Anwar’s educational journey reflects his strong foundation in pharmaceutical sciences. He earned his Doctor of Pharmacy (Pharm.D.) in 2011, followed by an M.Phil. (2013) and Ph.D. (2017) in Pharmaceutical Chemistry, all from Baqai Medical University, Karachi, Pakistan. His doctoral research explored the “Effect of Solvent, Ionic Strength, and Metal Ions on the Photolysis of Riboflavin and its Nanoparticles,” which laid the groundwork for his innovative work in drug photostability. In 2019, he was awarded a postdoctoral fellowship by the National Science Centre, Poland, at Adam Mickiewicz University in Poznan, focusing on the photophysical properties of pharmaceutical compounds. Dr. Zubair Anwar has also pursued advanced training in pharmaceutical management, pharmacology, and quality control, participating in various workshops such as SPSS analysis and current trends in pharmacy. His academic achievements underscore his commitment to advancing pharmaceutical sciences through both theoretical knowledge and practical applications.

🏢Work Experience:

Dr. Zubair Anwar’s professional career spans academia, research, and clinical practice. Beginning as a lecturer in 2013 at Baqai Medical University, he advanced to the roles of Assistant Professor and later Associate Professor and Deputy Director in Pharmaceutical Chemistry, a position he held until 2022. During this tenure, he led significant research projects funded by the Higher Education Commission (HEC) of Pakistan and guided several postgraduate students. Dr. Anwar also worked as a clinical pharmacist during internships at Ayub Medical Complex and the Central Drug Laboratory, Karachi. His postdoctoral fellowship at Adam Mickiewicz University in Poland further honed his expertise in spectroscopic methods and photophysical properties of pharmaceutical compounds. Beyond teaching and research, he has contributed to professional development through workshops, seminars, and curriculum design, making a lasting impact on the field of pharmaceutical education in Pakistan and internationally.

🏅Awards:

Dr. Zubair Anwar has received numerous accolades throughout his academic and professional career. Notable among these is the prestigious Postdoctoral Fellowship Award by the National Science Centre, Poland, which he completed at Adam Mickiewicz University, Poznan. He has also been recognized for his teaching and research excellence at Baqai Medical University, where he served in senior academic roles. Dr. Zubair Anwar holds commendation certificates for his participation in professional development programs, including those on SPSS analysis and pharmaceutical management. His contributions to clinical pharmacy were acknowledged during his internships at the Central Drug Laboratory, Karachi, and Ayub Medical Complex. Dr. Zubair Anwar has actively participated in international conferences, earning accolades for his presentations on drug photostability and pharmaceutical analysis. His research work has been extensively cited, showcasing his impact in pharmaceutical sciences. These honors reflect his dedication to advancing pharmaceutical education, research, and practice.

🔬Research Focus:

Dr. Zubair Anwar’s research centers on the photostability, degradation mechanisms, and analytical methods for pharmaceutical compounds. His doctoral studies focused on the “Effect of Solvent, Ionic Strength, and Metal Ions on the Photolysis of Riboflavin and its Nanoparticles,” highlighting his expertise in photochemical reactions. He has also investigated stability-indicating methods, drug interactions, and formulation strategies to enhance drug stability. During his postdoctoral fellowship at Adam Mickiewicz University, Poland, Dr. Zubair Anwar explored the spectroscopical and photophysical properties of pharmaceutical compounds, expanding his work to include innovative drug delivery systems. His research has practical implications in improving the shelf life and efficacy of pharmaceuticals. Dr. Zubair Anwar has guided numerous M.Phil. and Master’s students on projects involving riboflavin, thiamine, and other vitamins in pharmaceutical preparations. His work continues to impact pharmaceutical quality control, photochemical methodologies, and drug formulation research.

Publication Top Notes:

Ascorbic acid assisted photodegradation of methylcobalamin using corrective irrelevant absorption spectrophotometric assay: A kinetic study

Authors: Zahid, S., Anwar, Z., Qadeer, K., Vaid, F.H.M., Ahmad, I.

Citations: 0

Year: 2024

Journal: Spectrochimica Acta – Part A: Molecular and Biomolecular Spectroscopy

Volume: 323

Article No.: 124902

Photolysis of tolfenamic acid in aqueous and organic solvents: a kinetic study

Authors: Kazi, S.H., Sheraz, M.A., Anwar, Z., Heo, K., Na, J.-H.

Citations: 1

Year: 2024

Journal: RSC Advances

Volume: 14(30)

Pages: 21383–21397

Riboflavin (vitamin B2) sensitized photooxidation of ascorbic acid (vitamin C): A kinetic study

Authors: Noreen, A., Anwar, Z., Ahsan Ejaz, M., Khurshid, A., Ahmad, I.

Citations: 2

Year: 2024

Journal: Spectrochimica Acta – Part A: Molecular and Biomolecular Spectroscopy

Volume: 309

Article No.: 123813

Cyclodextrins and their applications in pharmaceutical and related fields

Authors: Khurshid, A., Anwar, Z., Khurshid, A., Sheraz, M.A., Ahmad, I.

Citations: 0

Year: 2024

Book Chapter: Profiles of Drug Substances, Excipients and Related Methodology

Degradation of fenamates

Authors: Kazi, S.H., Sheraz, M.A., Ahmed, S., Anwar, Z.

Citations: 0

Year: 2024

Book Chapter: Profiles of Drug Substances, Excipients and Related Methodology

Conclusion

In conclusion, if Assoc. Prof. Dr. Zubair Anwar has demonstrated a consistent record of impactful research, a robust publication history, and meaningful contributions to his field, he would be highly suitable for the “Best Researcher Awards.” His qualifications, research focus, mentorship role, and engagement in significant projects or collaborations are critical indicators of his eligibility. If the detailed data supports his achievements in these areas, he would be a strong contender for this prestigious award.

 

 

 

 

 

 

Prof. Ahmed elhenawy | Medicinal Chemistry |Best Researcher Award

Posted on by sciencefatherLeave a Comment on Prof. Ahmed elhenawy | Medicinal Chemistry |Best Researcher Award

Prof. Ahmed elhenawy | Medicinal Chemistry | Best Researcher Award

Prof. Ahmed elhenawy, Azhar unveristy, Egypt

Prof. Ahmed Abd El-Emonam El-Said El-Henawy is a distinguished Egyptian chemist, born on December 23, 1978, in Hellwan, Egypt. With an h-index of 22 and 126 publications, he is a prominent figure in organic chemistry, particularly in peptide synthesis and drug development. Currently, he serves as an Assistant Professor at Albaha University, KSA, and as a Professor at Al-Azhar University, Egypt. With extensive teaching experience, he has guided numerous undergraduate and postgraduate students in organic chemistry. His contributions to research and academia reflect a commitment to advancing knowledge in chemical sciences, emphasizing innovative approaches to synthesizing biologically active compounds.

Professional Profile:

Google Scholar

Orcid

Summary of Suitability for Award:

Prof. Ahmed Abd El-Emonam El-Said El-Henawy is an exemplary candidate for the “Best Researcher Awards,” primarily due to his substantial contributions to the field of organic chemistry and his commitment to advancing scientific knowledge. With an h-index of 22 and 126 publications, his research output demonstrates a high level of impact and relevance within the academic community. His specialization in peptide synthesis, particularly the development of novel amino acid derivatives with potential antimicrobial and anticancer activities, showcases his innovative approach to addressing critical health challenges.

🎓Education:

Prof. El-Henawy completed his Bachelor’s degree in Special Chemistry at Al-Azhar University in 2000. He pursued a Master’s degree in Organic Chemistry, focusing on amino acids and proteins, graduating in 2005. His doctoral research, completed in 2008, investigated new amino acid derivatives with expected biological activities. He has held various academic positions at Al-Azhar University, including Demonstrator, Assistant Lecturer, Lecturer, Associate Professor, and Professor, contributing to the department’s growth and the education of future chemists. Additionally, he has been involved in teaching at Albaha University since 2012, where he continues to inspire students through comprehensive organic chemistry courses.

🏢Work Experience:

Prof. El-Henawy has over two decades of experience in academia and research. He began his career as a Demonstrator at Al-Azhar University in 2002 and progressed to the role of Assistant Lecturer in 2005. He became a Lecturer in 2008, then an Associate Professor in 2014, and is currently a Professor. His research focuses on the synthesis of dipeptides and related compounds with potential antimicrobial and anticancer activities. He has developed expertise in various laboratory techniques, including multistep synthesis, chromatographic purification, and spectroscopic analysis. Prof. El-Henawy has supervised numerous M.Sc. and Ph.D. theses in peptide synthesis, reflecting his dedication to nurturing the next generation of chemists. His collaborative research has been presented at international conferences and published in reputable journals.

🏅Awards:

Prof. El-Henawy has received recognition for his contributions to the field of chemistry and education. His research has led to significant advancements in organic chemistry, particularly in synthesizing biologically active compounds. While specific awards are not listed, his h-index of 22 and 126 publications highlight his impact and credibility within the scientific community. His involvement in international conferences showcases his commitment to sharing knowledge and fostering collaboration among researchers. By mentoring students and guiding their research endeavors, he has played a vital role in shaping future chemists. Prof. El-Henawy’s dedication to teaching and research has earned him respect among colleagues and students alike, establishing him as a key figure in the chemistry department at both Al-Azhar University and Albaha University

🔬Research Focus:

Prof. El-Henawy’s research primarily focuses on organic chemistry, emphasizing peptide synthesis and the development of novel amino acid derivatives. His work includes synthesizing dipeptides, tri-, tetra-, and pentapeptides with antimicrobial properties. He has also explored new sulfonamide derivatives as potential antimicrobial agents and synthesized 2-amino-1,3,4-thiadiazole derivatives with anticancer potential. His research incorporates advanced laboratory techniques, such as multistep synthesis and chromatographic isolation. Prof. El-Henawy utilizes various spectroscopic methods to elucidate the structures of synthesized compounds, contributing to the understanding of their biological activities. His commitment to pharmacological research is evident in projects funded by Albaha University, focusing on the pharmacokinetics and toxicodynamics of pharmaceutical compounds. Through his innovative research, Prof. El-Henawy aims to discover new therapeutic agents that address critical health challenges.

Publication Top Notes:

  • Title: Exploring the anti-diabetic activity of benzimidazole containing Schiff base derivatives: In vitro α-amylase, α-glucosidase inhibitions and in silico studies
  • Title: Synthesis of novel thiazole derivatives containing 3-methylthiophene carbaldehyde as potent anti α-glucosidase agents: In vitro evaluation, molecular docking, dynamics, MM-GBSA …
  • Title: Experimental and computational profiling of novel bis-Schiff base derivatives bearing α-naphthalene moiety as potential tyrosinase inhibitors
  • Title: Flurbiprofen clubbed schiff’s base derivatives as potent anticancer agents: In Vitro and In Silico approach towards breast cancer
  • Title: Synthesis, anticancer, α-glucosidase inhibition, molecular docking and dynamics studies of hydrazone-Schiff bases bearing polyhydroquinoline scaffold: In vitro and in silico

 

 

 

Prof. Hendrik G Kruge | Pharmaceutical Chemistry | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Prof. Hendrik G Kruge | Pharmaceutical Chemistry | Best Researcher Award

Prof. Hendrik G Kruge | Pharmaceutical Chemistry | Best Researcher Award

Prof. Hendrik G Kruge , University of KwaZulu-Natal , South Africa

Prof. Hendrik Gerhardus Kruger is a distinguished Research Professor in Health Sciences at the University of KwaZulu-Natal, South Africa. With a specialization in organic chemistry, molecular modeling, and drug design, he has significantly impacted the scientific community. Holding a PhD in Chemistry from Potchefstroom University, he has published over 400 research papers and has mentored more than 100 postgraduate students and 30 postdoctoral fellows. Kruger is recognized for his contributions to curriculum development and his service to the scientific community. As a Fellow of the South African Chemical Institute, he has played a vital role in advancing research initiatives in the region. His innovative approach to rational drug design has positioned him among the leading scientists on the African continent, dedicated to addressing critical health challenges through cutting-edge research.

Professional Profile:

Google Scholar

Orcid

Scopus

Summary of Suitability for Award:

Prof. Hendrik Gerhardus Kruger is an exemplary candidate for the “Best Researcher Awards” due to his extensive contributions to the fields of chemistry and health sciences. His designation as a top researcher at the University of KwaZulu-Natal is a reflection of his innovative approach to drug design and molecular modeling, which has had a profound impact on the scientific community. Prof. Kruger’s work on metallo-beta-lactamase inhibitors, particularly the successful patent that is currently under consideration for clinical trials, demonstrates his ability to translate research into tangible health solutions.

🎓Education:

Prof. Hendrik Gerhardus Kruger obtained his PhD in Chemistry from Potchefstroom University, South Africa. His academic journey laid a strong foundation in organic chemistry, enabling him to specialize in molecular modeling and drug design. Throughout his educational career, he has continually sought to expand his knowledge and expertise, attending various workshops and conferences both nationally and internationally. His commitment to education extends beyond his own studies, as he has actively participated in mentoring students and developing curricula at the University of KwaZulu-Natal. His academic rigor and dedication to advancing chemical sciences have established him as a respected educator and researcher, contributing to the academic landscape in South Africa and beyond. Prof. Kruger’s comprehensive understanding of chemistry and its applications has driven his research endeavors and shaped his contributions to health sciences and drug development.

🏢Work Experience:

Prof. Hendrik Gerhardus Kruger boasts extensive experience in the field of chemistry, particularly in health sciences and drug design. As a Research Professor at the University of KwaZulu-Natal, he has led various research initiatives that emphasize rational drug design and biochemical analysis. Over the years, he has published more than 400 scientific papers and supervised over 100 postgraduate students and 30 postdoctoral fellows, reflecting his commitment to fostering the next generation of scientists. His leadership roles include serving on editorial boards for several reputable journals, including the South African Journal of Chemistry, where he has contributed to the advancement of organic chemistry. Kruger’s experience is further highlighted by his active involvement in industry collaborations, focusing on the development of innovative therapeutic solutions. His holistic approach to research, combining academic rigor with practical applications, has solidified his reputation as a leading figure in his field.

🏅Awards:

Prof. Hendrik Gerhardus Kruger has received numerous accolades for his outstanding contributions to the field of chemistry and health sciences. He is recognized as a top researcher at the University of KwaZulu-Natal, where his innovative work in drug design and molecular modeling has garnered significant attention. As a Fellow of the South African Chemical Institute (SACI), he has been acknowledged for his leadership and influence within the chemical community. His patent for metallo-beta-lactamase inhibitors, currently considered for clinical trials, is a testament to his impactful research. Kruger’s work has also earned him editorial appointments, where he has shaped the direction of scientific publishing. His recognition extends beyond academia, as he is often invited to speak at international conferences, further highlighting his expertise and commitment to advancing scientific knowledge. These honors reflect his dedication to excellence and his role in elevating the standards of chemical research.

🔬Research Focus:

Prof. Hendrik Gerhardus Kruger’s research focus centers on rational drug design, organic chemistry, and molecular modeling, with a commitment to addressing critical health challenges. His innovative work includes elucidating the mechanism of action of new metallo-beta-lactamase (MBL) inhibitors using advanced computational techniques such as hybrid quantum chemical methods and Umbrella sampling. Kruger is also expanding drug design efforts for second-generation MBL inhibitors and exploring new HIV integrase inhibitors. His research involves RNA analysis of pathogens to identify potential drug targets, aiming to enhance treatment strategies for diseases like tuberculosis (TB). By analyzing cellular processes at different treatment stages, his team seeks to shorten treatment times and improve patient outcomes. His multifaceted approach to drug development, combining fundamental research with practical applications, positions him at the forefront of chemical sciences and emphasizes his dedication to innovative therapeutic solutions.

Publication Top Notes:

  • Title: Green solid-phase peptide synthesis 2. 2-Methyltetrahydrofuran and ethyl acetate for solid-phase peptide synthesis under green conditions
    Citations: 7580
  • Title: Bis-and trisindolylmethanes (BIMs and TIMs)
    Citations: 643
  • Title: Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review
    Citations: 420
  • Title: The role of nanotechnology in the treatment of viral infections
    Citations: 388
  • Title: Therapeutic peptides

Khalid Khan | Organic Chemistry | Best Researcher Award

Posted on by sciencefather

Assoc Prof Dr. Khalid Khan | Organic Chemistry | Best Researcher Award

Associate Professor at Islamia College University, Peshawar, Pakistan

Dr. Khalid Khan is an accomplished chemist with extensive expertise in organic chemistry and medicinal research. He obtained his PhD from Huazhong University of Science and Technology in China, focusing on the design and synthesis of novel dendro-calix[4]arenes. Currently, he serves as an Associate Professor at Islamia College University in Peshawar, Pakistan, where he leads various research projects and supervises graduate and undergraduate students. His work has significantly contributed to the field of drug discovery, particularly in computational and medicinal chemistry.

Author Metrics

Scopus Profile

Dr. Khan has published over 25 research articles in reputable journals, showcasing his research impact and contribution to the field of chemistry. His work has garnered numerous citations, reflecting the relevance and influence of his research on both national and international platforms. His publication metrics highlight his active engagement in advancing scientific knowledge, particularly in the areas of antiviral drug development and nanotechnology.

  • Citations: 414 citations across 379 documents
  • Documents: 21 published works
  • h-index: 9

Education

Dr. Khan completed his PhD in Chemistry from Huazhong University of Science and Technology, China (2008-2013), where he conducted groundbreaking research on nonionic amphiphilic dendro-calix[4]arenes. He holds a Master’s degree in Chemistry from the University of Peshawar (2002-2004), where he graduated with first-class honors, and a Bachelor’s degree in Biological Science from Government College Peshawar (2000-2002).

Research Focus

Dr. Khan’s research primarily revolves around organic chemistry, with a special focus on the synthesis and characterization of bioactive compounds. He is particularly interested in the development of antiviral agents and the computational modeling of drug interactions with viral proteins. His innovative research projects often explore the structure-activity relationships of compounds to enhance therapeutic efficacy.

Professional Journey

Beginning his career as a lecturer in 2005, Dr. Khan progressively advanced to the role of Associate Professor in 2020 at Islamia College University. Throughout his tenure, he has significantly contributed to the academic environment by designing curricula, supervising research, and engaging in community service. His professional journey is marked by a commitment to education, research, and the development of future scientists.

Honors & Awards

Dr. Khan has received several prestigious awards, including the Pakistan and Chinese Government Cultural Exchange Scholarship for his doctoral studies. He was recognized as the topper in his Master’s program, reflecting his dedication and excellence in the field of chemistry. His achievements have earned him a respected place among his peers in academia.

Publications Noted & Contributions

Among his numerous publications, key works include research on the design and synthesis of novel dendro-calix[4]arenes, antiviral drug development, and the characterization of compounds with potential therapeutic applications. His contributions have advanced understanding in various areas of organic chemistry and nanotechnology, facilitating further research in these domains.

Homology modeling and molecular docking study of metabotropic glutamate receptor 5 variant F: An attempt to develop drugs for treating CNS diseases

  • Authors: Ahmad, N., Khan, K., Rashid, H.U., Ullah, R., Ali, E.A.
  • Journal: Zeitschrift für Physikalische Chemie
  • Year: 2024
  • Volume: 238, Issue 8, Pages 1551–1577
  • Citations: 1

Direct synthesis, characterization, in vitro and in silico studies of simple chalcones as potential antimicrobial and antileishmanial agents

  • Authors: Ur Rashid, H., Khan, S., Irum, Shah, T., Khan, K.
  • Journal: Royal Society Open Science
  • Year: 2024
  • Volume: 11, Article 240410
  • Citations: 0

Homology modeling and molecular docking study of corticotrophin-releasing hormone: An approach to treat stress-related diseases

  • Authors: Ahmad, N., Khan, K., Khan, S.W., Ullah, R., Ali, E.A.
  • Journal: Open Chemistry
  • Year: 2024
  • Volume: 22, Article 20240069
  • Citations: 0

Biological investigations of Aspergillus ficuum via in vivo, in vitro and in silico analyses

  • Authors: Shah, Z.A., Khan, K., Shah, T., Muhammad, A., Rashid, H.
  • Journal: Scientific Reports
  • Year: 2023
  • Volume: 13, Article 17260
  • Citations: 1

Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques

  • Authors: Shah, Z.A., Khan, K., Rashid, H.U., Jaremko, M., Iqbal, Z.
  • Journal: BMC Microbiology
  • Year: 2022
  • Volume: 22, Article 295
  • Citations: 4

Research Timeline

Dr. Khan’s research trajectory spans over a decade, beginning with his PhD studies from 2008 to 2013, followed by various research projects involving computational analyses and synthesis of organic compounds. His ongoing projects encompass a wide range of studies aimed at understanding and inhibiting viral proteins, particularly related to SARS-CoV-2 and other pathogenic viruses.

Collaborations and Projects

Dr. Khan has collaborated with both national and international researchers on diverse projects, enhancing the scope and impact of his research. These collaborations have resulted in joint publications and a collective effort to address significant challenges in medicinal chemistry and virology. His ability to work across disciplines and institutions underscores his commitment to collaborative scientific inquiry.

Conclusion

Dr. Khalid Khan’s recognition as a Best Researcher reflects his significant contributions to organic chemistry and medicinal research. His publication record and collaborative efforts enhance his impact within the scientific community. By addressing areas for improvement, such as increasing citation metrics and expanding research diversification, Dr. Khan can further strengthen his position as a leader in his field. His commitment to education and research not only benefits his students but also contributes to the broader scientific landscape, making his work essential for advancements in drug discovery and public health.